The value-for-money assessment and funding arrangements for high-priced drugs in an era of uncertainty: a comparative analysis of national health technology assessment agencies in South Korea, England, Australia, and Canada.

Saved in:
Bibliographic Details
Title: The value-for-money assessment and funding arrangements for high-priced drugs in an era of uncertainty: a comparative analysis of national health technology assessment agencies in South Korea, England, Australia, and Canada.
Authors: Hong J; Department of Healthcare Management, Gachon University, Seongnam-Si, Gyeonggi-Do, Republic of Korea., Bae EY; College of Pharmacy, Gyeongsang National University, 501 Jinju-Daero, Jinju, 52828, Republic of Korea. eybae@gnu.ac.kr., Cha S; College of Pharmacy, Gyeongsang National University, 501 Jinju-Daero, Jinju, 52828, Republic of Korea., Lee J; College of Pharmacy, Gyeongsang National University, 501 Jinju-Daero, Jinju, 52828, Republic of Korea.
Source: BMC health services research [BMC Health Serv Res] 2025 Jan 14; Vol. 25 (1), pp. 74. Date of Electronic Publication: 2025 Jan 14.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1472-6963
DOI:10.1186/s12913-025-12207-9